To describe the clinical characteristics and risk factors associated with poor outcome in infants <90 days of age with bacterial meningitis. Methods: Prospective, enhanced, national population-based active surveillance for infants <90 days of age with bacterial meningitis in the United Kingdom and Ireland between July 2010 and July 2011. Infants were identified through the British Paediatric Surveillance Unit, laboratory surveillance and meningitis charities. Results: Clinical details was available for 263 of 298 (88%) infants where a bacterium was identified, 184 (70%) were born at term. Fever was reported in 143 (54%), seizures in 73 (28%), bulging fontanelle in 58 (22%), coma in 15 (6%) and neck stiffness in 7 (3%). Twenty-three (9%) 
B acterial meningitis remains a major cause of morbidity and mortality worldwide, with the highest incidence reported in young infants. 1 In a national prospective surveillance study of bacterial meningitis in infants <90 days of age across the United Kingdom and the Republic of Ireland undertaken during 2010/2011, we identified 364 cases equating to an annual incidence of 0.38/1000 live-births. Group B streptococci (GBS) and Escherichia coli remain the main pathogens responsible, and no cases of meningitis due to Listeria monocytogenes were identified beyond 30 days of age. 2 Among 329 cases for which outcome data were available, the case fatality rate (CFR) was 8%. 2 When compared with UK studies conducted during the 1980s 3 and 1990s, 4 neither the incidence nor the case fatality in neonates with bacterial meningitis has changed despite the introduction of multiple national initiatives [5] [6] [7] [8] [9] and guidelines. [10] [11] [12] With the possible exception of a GBS vaccine for pregnant women, 13, 14 there are no prospects for new vaccines to prevent serious bacterial infections in neonates. Studies in older children and adults suggest that there may be opportunities for improving the outcomes of meningitis through earlier identification and better clinical management. [15] [16] [17] In recognition of this, a number of guidelines focusing on serious infections (including meningitis) in children have been introduced in the United Kingdom and United States in the last decades. 11, 12, 18, [19] [20] [21] They all specify fever as a key feature of infection. There are also specific bacterial meningitis management guidelines in the United States 22 and Europe. 23 In this study, we analyzed clinical data from the 2010-2011 cohort to describe the clinical features, management, outcome and risk factors for poor outcomes in young infants with confirmed bacterial meningitis. 2 Data on the incidence, demographics and etiology have already been published. 2 
MATERIALS AND METHODS

Infants
Clinical Characteristics and Risk Factors for Poor Outcome in Infants Less Than 90 Days of Age With Bacterial Meningitis in the United Kingdom and Ireland
were identified through the British Paediatric Surveillance Unit, as described previously. 2 Briefly, all pediatricians across the United Kingdom and the Republic of Ireland are requested by the British Paediatric Surveillance Unit to report cases of specified diseases on a monthly basis and then to complete a standard questionnaire using information documented in the medical notes during the acute admission. 24 The questionnaire sought information on demographics, risk factors, clinical presentation, management and outcomes at the time of questionnaire completion (usually at ≥1 month after diagnosis).
To improve ascertainment, other sources were also utilized, including contacting individual hospital microbiology laboratories, querying LabBase2 25 (a national surveillance database to which hospital laboratories in England and Wales voluntarily report clinically significant infections electronically to Public Health England) and contacting national meningitis and GBS charities.
Data Analysis
Completed questionnaires were entered into Microsoft Access and analyzed using STATA v.12.0 (Statacorp, College Station, TX). Infants with intraventricular shunt devices or neural tube defects were excluded. Definitions of normal ranges for cerebrospinal fluid (CSF) white cell counts (WCCs) were based on published data, 26, 27 with no adjustments made for traumatic taps. 28 For analysis, a confirmed bacterial meningitis case was defined as isolation of a significant bacterial pathogen from the CSF or isolation of a significant bacterial pathogen from blood cultures in an infant with CSF pleocytosis. CSF pleocytosis was defined as ≥20 cells/mm 3 for babies 0-28 days of age and ≥10 cells/ mm 3 for babies 29-89 days of age. Infants with clinical signs of meningitis [fever (temperature ≥38°C) or hypothermia (<36.5°C) or temperature instability (defined as wide variations in temperature)], together with 1 or more neurologic findings (coma, seizures, neck stiffness, apnea, bulging fontanelle) and a positive blood culture with a significant pathogen, who were treated with appropriate intravenous antibiotics for >7 days, but in whom a CSF sample was not obtained, were also included in this group. Additionally, infants who had these clinical features but were deemed to be too unstable for a lumbar puncture (LP) but who had a bacterium identified from the blood culture and subsequently died with meningitis recorded on their death certificate were also classified as confirmed bacterial meningitis. A nonconfirmed bacterial meningitis case was defined as an infant with clinical signs of meningitis and CSF pleocytosis, who received antibiotic therapy to treat bacterial meningitis, but no significant pathogen was isolated from blood or CSF.
According to UK national guidelines, "Red flag" clinical indicators for early-onset infection in neonates included respiratory distress after 4 hours of birth, signs of shock, seizures and need for mechanical ventilation in a term infant; these were noted for all relevant cases. 18 Complications were classified as serious central nervous system (CNS), nonserious CNS or non-CNS complications. Antibiotic susceptibility data were obtained from routine local and national laboratory reports from Public Health England (PHE's) LabBase2 database. Pathogens were considered susceptible if reported as susceptible to ≥1 of the recommended empiric antibiotics used. 29 For streptococci and L. monocytogenes, susceptibility to penicillin was used as a proxy for amoxicillin/ampicillin susceptibility if the latter agents were not reported. Penicillin susceptibility was also used to impute cefotaxime susceptibility in streptococci but not for L. monocytogenes.
Continuous data that did not follow a normal distribution were reported using medians with interquartile ranges [interquartile range (IQR), 9 .49] and compared using the Mann-Whitney U or Kruskal-Wallis equality of population rank test, as appropriate. Proportions were compared using χ 2 or Fisher exact test, as appropriate. To identify independent risk factors for poor outcomes (death or serious CNS complications), a backward, stepwise multivariable logistic regression model was developed for confirmed bacterial meningitis cases. In addition to age in days and sex, all parameters in the univariate analysis with a P<0.2 were incorporated into the model. The least significant parameter was then sequentially removed until only those parameters with P<0.05 remained. In the model, either gestation at birth or birthweight was used because of co-dependency. Odds ratio, 95% confidence interval (CI) and respective P values are reported.
RESULTS
A total of 298 cases of confirmed bacterial meningitis was identified, in 263 (88%) full clinical details were available. Subsequent description and analyses (except antibiotic susceptibilities of isolated pathogens) were performed on the 263 cases. Of these cases, 187/263 (71%) had a bacterium identified in the CSF including 1 case where the bacterium was from a cerebral abscess, 66/263 (25%) had CSF pleocytosis with a bacterium isolated from blood culture and 10/263 (4%) had clinical features of meningitis and a bacterium from blood culture (5 were deaths with meningitis recorded on the death certificate and 5 were deemed to be too unstable for an LP and were treated with antibiotics for more than 7 days).
Most cases (153/263; 58%) were male, and 184/263 (70%) were <30 days of age. The majority (184/263; 70%) were born at term, 77/263 (29%) were preterm with gestation not recorded in 2 (1%) cases. Sixty-four percent of cases (168/263) were admitted from home while 93/263 (35%) were already in-patients at the time of diagnosis and in 2 (1%) the source of admission was not recorded. Demographic details are shown in Table 1 .
Clinical Features
Most infants had nonspecific clinical presentations; the "classic" features of meningitis (seizures, bulging fontanelle, coma and neck stiffness) were reported in 73 (28%), 58 (22%), 15 (6%) and 7 (3%) of cases, respectively. Fever (≥38°C) at presentation was reported in only 143 (54%) cases, and temperature instability (wide variations in temperature) or hypothermia (<36.5°C) was reported in 56 (21%). Abnormal temperature, that is, fever or temperature instability or hypothermia, was reported in 176 (67%) of cases ( Table 1) .
The most common combinations of clinical features were fever and irritability 109 (41%); fever and lethargy 93 (35%); fever, lethargy and poor feeding 83 (32%); fever, irritability and poor perfusion 55 (21%); and fever and seizures 35 (13%). The triad of seizures, bulging fontanelle and neck stiffness were present in only 4 infants (2%).
Presenting features varied by route of admission, gestation at birth and month of life ( Preterm infants were more likely to have temperature instability and apnea than term infants. Conversely, term infants were more likely to have poor feeding, irritability, fever and vomiting ( Neonates were more likely to have convulsions than older infants whereas older infants were more likely to have abnormal temperature, fever and bulging fontanelle ( Infants with fever at presentation were older [median age, 21 days (IQR, 8-46)] than infants without fever (10 days IQR 2-27; P = 0.0001). They were also more likely to be irritable, have poor feeding and present with a bulging fontanelle. On the other hand, infants without fever were more likely to have apnea; 40 (Table 2) .
On the other hand, seizures were more common in infants with GBS and pneumococcal meningitis [50/135 (37%) and 9/26 (35%)] compared with other bacteria 14/102 (14%), P < 0.0001 and 0.01, respectively.
A quarter of infants (68/263, 26%) presented before 72 hours of age (51 in-patients, 17 from home). Overall, 85% (n = 58) of them had significant clinical features ("red flags"), such as respiratory distress (48/68, 71%), seizures (32/68, 47%) or poor perfusion (32/68, 47%). However, only 38% (26/68) in this group had fever at presentation.
Lumbar Puncture
An LP was performed in 253/263 cases (96%), either before (n = 90, 36%) or after (n = 154, 61%) the first antibiotic dose; in 9 cases (4%), the timing was not reported. An LP was not performed in 10 cases (4%), 5 of whom died and had a bacterium identified in their blood cultures and also had meningitis recorded on their death certificate, and 5 who were deemed to be too unstable for an LP but had a bacterium isolated from blood culture.
Infants admitted from home were more likely to have had an LP before antibiotics (73/160, 46%) compared with those already in hospital (17/92, 18%; P < 0.0001). Similarly, infants without fever were more likely to have an LP after antibiotics 81/120 (68%) versus 73/143 (51%), P = 0.007. Infants with an LP performed before antibiotics were more likely to have a bacterium identified from the CSF than those with an LP performed after antibiotics [83/90 (92%) vs. 94/154 (61%); P < 0.0001].
CSF Results
The median CSF WCC, protein and glucose values varied significantly between specific pathogens (Table 3 ). The CSF WCC was <20 cells/mm 3 in 17/181 (9%) of neonates (0-28 days olds) and <10 cells/mm 3 in 8/82 (10%) of older infants. In 4 cases, there were no white cells in the CSF, but a single pathogen was isolated. The percentage of polymorphonuclear WCC was >50% in 84% (n = 146) and was 100% in only 10% (n = 17) of 174 infants where this was reported.
Blood Culture Results
Blood cultures were negative in 68/263 (26%) infants. Where a bacterium was identified in the CSF, blood cultures were negative in 36% (68/187), including 27% (17/63) with early-onset (<7 days) and 41% (51/124) with late-onset (7-89 days) meningitis (P = 0.06). In all cases where a pathogen was identified in both blood and CSF (n = 120), the isolates were concordant. In 75/263 (29%), a pathogen was isolated from blood culture but not from CSF; of these, 59/75 (79%) had the LP performed after antibiotic administration.
Antibiotic Susceptibility, Management and Adjunctive Therapy
Antibiotic susceptibility was reported for 242/302 (80%) bacteria and 240 (99%) were susceptible to the combination of cefotaxime plus amoxicillin/ampicillin ( Altogether, 27 different empiric antibiotic combinations were used. The combinations varied according to route of admission, with penicillin/gentamicin being favored among in-patients (34/92, 37%) and either cephalosporin and amoxicillin (60/162, 37%) or cephalosporin alone (35/162, 22%) among those admitted from home (Table, Supplemental Digital Content 5, http://links. lww.com/INF/C965). An aminopenicillin was given in 128/179 (72%) infants <30 days of age and nearly half of older infants 38/77 (49%). In 11/240 (6%) surviving infants, the antibiotic course was completed at home.
A corticosteroid was prescribed in 20 cases (8%); (relevant bacteria: GBS 9, pneumococcus 6, meningococcus 3, E. coli 1 and L. monocytogenes 1). The median time of corticosteroid administration after antibiotics was 10 (IQR, 6-12) hours.
Outcomes
Twenty-three of 263 infants died; CFR was 9% (95% CI: 6%-13%). The median duration of admission for survivors was 16 days (IQR, 13-22) compared with 3 days (IQR, 0-7) for nonsurvivors (P = 0.0001). The CFR in infants treated empirically with a third-generation cephalosporin did not differ significantly in comparison with treatment with any other empiric antibiotic combination [5% (9/171) vs. 12% (10/85), respectively, P = 0.06]. Similarly, the CFR in infants receiving corticosteroids did not differ significantly compared with those who did not receive corticosteroids [15% (3/20) vs. 8% (20/243), respectively, P = 0.4].
In the multivariable logistic regression model, the risk of a fatal outcome was independently associated with prematurity, coma on admission and pneumococcal meningitis (Table 4 ). In particular, premature birth (<37 weeks gestation) was independently associated with a 5.84-fold increased risk of death (95% CI: 2.02-16.85; P < 0.0001), and the risk increased with the degree of prematurity, from 2.14 (95% CI: 0.48-9.65; P = 0.32) among infants born at 32 to <37 weeks gestation, to 5.73 (95% CI: 1.08-30.41; P = 0.04) at 28 to <32 weeks gestation and 26.27 (95% CI: 6.22-110.98; P < 0.0001) at <28 weeks gestation. A similar trend was observed when prematurity status was replaced with birthweight in the logistic regression model (Table 4) Among survivors, a serious CNS complication (seizures 26, motor disorder or abnormal neurology 24, hydrocephalus with or without a ventriculoperitoneal shunt 15, hearing loss 8 or extradural collection requiring neurosurgical intervention 1) was reported in 23% (56/240). Twenty-one others (9%) had nonserious CNS or non-CNS complications (Table 5 ). Among survivors, the rate of serious CNS complications varied by specific bacteria, with the highest complication rates among those with pneumococcal meningitis (10/21, 48%) compared with other bacteria (46/219, 21%, P = 0.006) [GBS (27/128, 21%), E. coli (6/31, 19%), †In the logistic regression model, either gestation at birth or birthweight was used at a time because of codependency. When prematurity was replaced with birthweight, OR for death increased by 8.48-fold (95% CI: 2.60-27.69; P < 0.0001). Compared with infants of normal birthweight (≥2500 g), there was a trend of increased risk of death with decreasing birthweight from 3.51 (95% CI: 0.79-15.53; P = 0.099) for birthweight 1500-1499 g and 19.15 (95% CI: 4.78-76.80; P < 0.0001) for birthweight <1500 g.
CT indicates computerized tomography; MRI, magnetic resonance imaging. In the backward, stepwise, multivariable logistic regression analysis, individual risk factors with a P value of <0.2 in the univariate analysis where included, along with age and sex. OR, 95% CI and P values are reported for age, sex and significant risk factors only. Among survivors, the risk of serious CNS complications was independently associated with temperature instability, seizures, pneumococcal meningitis and elevated CSF protein (Table 5 ).
DISCUSSION
We found that the classic clinical features associated with bacterial meningitis were uncommon in young infants, which is consistent with previous reports. 30, 31 In particular, the absence of fever in nearly half of cases is striking because national and international guidelines usually regard fever as the trigger for further evaluation of a serious underlying infection in children. 12, [19] [20] [21] Clinicians must, therefore, still consider bacterial meningitis in their differential diagnosis of an unwell infant, even in the absence of fever. In our cohort, 52% of nonfebrile infants had other features suggestive of bacterial meningitis, particularly apnea and seizures (Supplemental Digital Content 6, http://links.lww.com/INF/C966).
Our results also highlight the importance of performing an LP when investigating infants suspected to have a serious infection. Consistent with published reports (62%-85%), [32] [33] [34] only 74% of infants in our cohort had positive blood cultures. Therefore, negative blood culture cannot be relied upon to exclude the diagnosis of underlying bacterial meningitis. Other large studies have shown that 30%-50% of infants evaluated for sepsis in neonatal units did not undergo an LP, 35, 36 raising concerns that meningitis may be underdiagnosed. Our study highlights the need to perform the LP before initiating antibiotics whenever possible as the yield from CSF cultures is significantly lower in samples taken after antibiotic administration. At the same time, up to 10% of infants with proven bacterial meningitis have initially normal CSF parameters (similar to 13% reported in a previous study), 26 emphasizing the need to await laboratory results before stopping empiric antibiotics. Confirming the diagnosis of bacterial meningitis and identifying the responsible pathogen have important implications in terms of the choice and duration of antimicrobial therapy, as well as planning long-term investigations and follow-up care.
The wide variation in empiric antibiotic use is also notable and could be due to a number of factors, including gestational age, prior antibiotic exposure or local guidelines. Our study supports the current UK national recommendations for empiric antibiotic treatment in young infants with suspected bacterial meningitis in children <16 years. 11 Based on antibiotic susceptibility data, cefotaxime/amoxicillin was an appropriate treatment option in nearly all cases, especially those admitted from home and in-patient infants born at term. The absence of L. monocytogenes among cases of meningitis older than 1 month in our cohort, 2 and its rarity in other similar cohorts, [37] [38] [39] suggests that third-generation cephalosporins alone are adequate for empiric treatment after the first month of life. Despite lack of evidence and recommendations against the use of steroids, 11 8% of infants still received steroids, similar to the 8% reported in neonates in the 1990s. 4 This indicates ongoing uncertainty regarding the role of dexamethasone in this age group. 40 It is likely that steroids were administered to the most severe cases in our cohort, which may explain the long interval between empiric antibiotic and corticosteroid administration and the higher CFR.
We also identified a number of factors that are associated with poor outcomes, some of which have also been identified in previous studies of children, 41 and adults with bacterial meningitis. 42 Coma and seizures are well-established proxies for severe illness. †Serious CNS complications. Twenty-one other infants (7%) were reported to have either nonserious, non-CNS or abnormalities that may be deemed part of the natural history of meningitis: infarct on CT/MRI (n = 8), subdural collection/abscess (n = 6), ventriculitis (n = 2), musculoskeletal abnormality/soft tissue infection (n = 4), submandibular abscess (n = 1) and endocarditis (n = 1). These were not included in the multivariate analysis.
‡In the logistic regression model, CSF protein was included as a binary variable, whereby those above the median concentrations for the whole cohort (2275 mg/dL) were compared with those below.
CT indicates computerized tomography; MRI, magnetic resonance imaging. In the backward, stepwise, multivariable logistic regression analysis, individual risk factors with a P value of <0.2 in the univariate analysis were included, along with age and sex. OR, 95% CI and P values are reported for age, sex and significant risk factors only.
Pneumococcal meningitis is associated with high case fatality and severe long-term neuro-disabilities among survivors, and this was also observed in our cohort. Prematurity and low birthweight are both well-known and potentially modifiable risk factors through optimal care in pregnancy and prevention of preterm delivery. Further studies should evaluate how the identified risk factors may be used to improve the clinical management of patients, counseling the parents about prognosis and planning ongoing and long-term care.
Strengths and Limitations
Our results are generalizable to industrialized countries where GBS and E. coli remain the leading causes of bacterial meningitis in young infants. 43, 44 In contrast to laboratory-based surveillance alone, the use of practical and broad clinical case definitions and multisource reporting ensured high case ascertainment, allowing more comprehensive analysis of cases that are more typical of a clinical setting, such as those where an LP was not performed, or cases where the pathogen was only identified in blood. Although both constitute a small proportion of the cases defined in this study, they do highlight the varied scenarios encountered by treating clinicians.
In this analysis, we excluded cases where a bacterium was not identified despite being treated as bacterial meningitis by the clinician. However, recent reports show that bacteria identification in these infants would have been enhanced using nonculture methods especially in those pretreated with antibiotics before an LP. 45 
